Accelerated Vaccine Development During COVID-19

This chapter examines the rapid development of COVID-19 vaccines, emphasizing the role of regulatory bodies in expediting clinical trials while maintaining strict safety standards. It also discusses the implications of the FDA's full approval, including the rise of vaccine mandates in various sectors and the flexibility for physicians to prescribe off-label vaccines for high-risk patients.